Affiliated with a Castle Connolly Top Hospital
Who is Dr. Schatzberg, Psychiatrist in Stanford, CA?
Dr. Alan Schatzberg, MD is a Psychiatrist, who primarily practices in Stanford, CA with 1 additional practice location. He is board certified. Dr. Schatzberg completed his residency at Mass Mntl Hlth Ctr, Psychiatry; Lenox Hill Hosp, Flexible Or Transitional Year. Dr. Schatzberg is fluent in English and German, and is currently seeing new patients. Dr. Schatzberg’s practice accepts Medicare, Aetna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Schatzberg’s office at (650) 498-5710.
What are Areas of Expertise for Dr. Schatzberg?
Dr. Alan Schatzberg, MD is a highly-rated, board-certified Psychiatrist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Schatzberg empowers patients to confidently navigate their health journey, specializing in Anxiety & Mood Disorders, Depression, Psychopharmacology, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Schatzberg is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Schatzberg go to medical school and complete their residency?
Fellowship: Harvard Medical School MA | Harvard Medical School
Residency: Mass Mntl Hlth Ctr, Psychiatry; Lenox Hill Hosp, Flexible Or Transitional Year | Mass Mental Health Center | Massachusetts Mental Health Center | Mass Mental Health Center, Resident:Psychiatry | Massachusetts Mental Health Center
Medical School: New York Univ Sch of Med, New York Ny
Is Dr. Schatzberg board certified as a Psychiatrist?
Yes, Dr. Alan Schatzberg, MD is board certified by the American Board of Psychiatry and Neurology , American Board of Psychiatry and Neurology since 1975
What languages does Dr. Schatzberg speak?
Dr. Schatzberg and their clinical team can communicate with patients in the following languages:
English
German
What conditions does a Psychiatrist like Dr. Schatzberg typically treat?
As a Psychiatrist, Dr. Schatzberg diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Schatzberg. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Bipolar II Disorder
- Bipolar Disorder
- Bipolar 2
- Bipolar with hypomania and depression
- Mild bipolar disorder
ICD-10 Codes:
- F3181: Bipolar II disorder
Also known as:
- Moderate Recurrent Major Depression
- Depression
- Moderate chronic depression
- Moderate recurring depression
- Moderate depressive episodes
ICD-10 Codes:
- F331: Major depressive disorder, recurrent, moderate
Also known as:
- Autism
- Autism Spectrum Disorder
- Classic Autism
- Kanner's Syndrome
- Severe Autism
ICD-10 Codes:
- F840: Autistic disorder
Also known as:
- Generalized Anxiety Disorder
- Anxiety
- GAD
- Chronic Worry
- Excessive Worry Disorder
ICD-10 Codes:
- F411: Generalized anxiety disorder
What procedures does a Psychiatrist like Dr. Schatzberg typically perform?
As a Psychiatrist, procedures performed by Dr. Alan Schatzberg may include:
- Child Psychiatry Consultation
- Child Psychiatry Follow Up
- Cognitive Behavioral Therapy (CBT)
- Couples Therapy
- Electroconvulsive Therapy (ECT)
- Hypnotherapy
- Inpatient Psychiatric Services
- Ketamine Infusion
Please contact Dr. Schatzberg's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Schatzberg accept my insurance?
Dr. Schatzberg accepts most major insurance plans. Important: Please call our office at (650) 498-5710 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Schatzberg accept in Stanford, CA?
Dr. Schatzberg in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Aetna
All Other Third Party
Blue Cross Blue Shield
Blue Cross Blue Shield of Illinois
Blue Shield of California
CVS Health (formerly Aetna)
Elevance Health Inc. (formerly Anthem)
Medicare
UnitedHealth Group
Unknown
View All Insurances
Where is Dr. Schatzberg's office located?
Recognitions
Awards
Cornell Med College
Gerald Klerman Award
College Of Psychiatrist
Award For Research Am Psychiatry Assoc
(ndmda)
U Pennsylvania, .
Edward A. Streckler Award
Third Intl Forum On Mood & Anxiety Disorder Awd
Institute Of Medicine
Anna Monika Prize, Anna Monika Foundation
Honoris Causa, Medical Doctor, Mediziniche Universitat, Wien
National Alliance for Research in Schizophrenia and Affective Disorde
Falcone Award
The American College of Psychiatrists
Distinguished Service in Psychiatry Award
Elected Member, Institute of Medicine of the National Academy of Scie
American Psychiatric Association
Research Award
American College of Psychiatrists
Mood Disorders Research Award
Edward A. Strecker, MD Award,
University of Pennsylvania School of Medicine
Cornell Medical College
Klerman Award
MD Lifetime Research Award, National Depressive and Manic Depressive
Gerald L. Klerman
Publications
The mineralocorticoid receptor agonist, fludrocortisone
, 2013
Common Abnormalities
, 2011
Somatic and neuroendocrine responses to standard and biologically salient acoustic startle
, 2011
Markers in the 15q24 Nicotinic Receptor Subunit Gene Cluster
, 2011
Aberrant Brain Activation During a Working Memory Task in Psychotic Major Depression
, 2011
Animal Models of Early Life Stress: Implications for Understanding Resilience
, 2010
Persolity traits and medical outcome of cardiac illness
, 2010
Presidential address.
, 2010
Failure to improve cigarette smoking abstinence with transdermal selegiline plus cognitive behavior
, 2010
Stress coping stimulates hippocampal neurogenesis in adult monkeys
, 2010
ABCB1 ( MDR1) polymorphisms and antidepressant response in geriatric depression
, 2010
Prelimiry evidence that plasma oxytocin levels are elevated in major depression
, 2010
Chronic pain and major depressive disorder in the general population
, 2010
Failure of Anterior Cingulate Activation
, 2010
Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder A Multicenter
, 2010
Social phobia and depression: Prevalence and comorbidity
, 2010
FKBP5 Polymorphisms and Antidepressant Response in Geriatric Depression
, 2010
Using Treatment Process Data to Predict Maintained Smoking Abstinence
, 2010
Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study
, 2010
Monitoring mental health treatment acceptance
, 2010
A pilot study of the phase angle between cortisol
, 2010
Disrupted Amygdalar Subregion Functiol Connectivity
, 2009
Withdrawal symptoms over time among adolescents in a smoking cessation intervention
, 2009
The silver lining of recent effectiveness trials
, 2009
Prefrontal Plasticity and Stress Inoculation-Induced Resilience
, 2009
Developmental cascades linking stress inoculation, arousal regulation, and resilience
, 2009
Extended cognitive behavior therapy for cigarette smoking cessation
, 2008
Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression
, 2008
The acute and post-discontinuation effects of a glucocorticoid receptor
, 2008
Glucocorticoid antagonists in neuropsychotic disorders
, 2008
Stress-induced changes in primate prefrontal profiles of gene expression
, 2007
Prelimiry evidence that hippocampal volumes
, 2007
The acute effects of a mineralocorticoid receptor
, 2007
Resting-state functiol connectivity in major depression
, 2007
Early life stress and novelty seeking behavior in adolescent monkeys
, 2007
Current issues in the classification of psychotic major depression
, 2007
Serotonin transporter polymorphism, memory and hippocampal volume in the elderly
, 2007
Impact of publicity concerning pediatric suicidality data on physician practice patterns
, 2007
New paradigm for treating recurrent depression
, 2006
Social stress-related behavior affects hippocampal cell proliferation in mice
, 2006
The neuropsychological profile of psychotic major depression and its relation to cortisol
, 2006
Cortisol circadian rhythm alterations in psychotic major depression
, 2006
Extended treatment with bupropion SR for cigarette smoking cessation
, 2006
A double-blind, placebo
, 2006
Application of microarray technology in primate behavioral neuroscience research
, 2006
Clinical and biological effects of mifepristone treatment for psychotic depression
, 2006
Materl mediation, stress inoculation
, 2006
Detecting psychotic major depression using psychiatric rating scales
, 2006
Antidepressant discontinuation syndrome
, 2006
Intrasal oxytocin administration attenuates the ACTH stress response in monkeys
, 2005
The efficacy of divalproex sodium in the treatment of agitation associated with major depression
, 2005
Monoamine oxidase and catechol
, 2005
Nocturl sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon 4 carriers
, 2005
The efficacy of antidepressants in the treatment of late-life depression
, 2005
Chronic depression - Medication (nefazodone) or psychotherapy (CBASP) is effective when the other
, 2005
Aging and the role of the HPA axis and rhythm in sleep and memory-consolidation
, 2005
Review: On the interactions of the hypothalamic-pituitary-adrel (HPA) axis and sleep
, 2005
Mild early life stress enhances prefrontal-dependent response inhibition in monkeys
, 2005
Mutations in squirrel monkey glucocorticoid receptor impair nuclear translocation
, 2005
A randomized trial of the efficacy of group therapy in changing viral load and CD4 counts in
, 2005
Effects of the serotonin transporter gene promoter polymorphism on mirtazapine
, 2004
Major depression among adolescent smokers undergoing treatment for nicotine dependence
, 2004
Prospective investigation of stress inoculation in young monkeys
, 2004
Randomized clinical trial of the efficacy of Bupropion combined with nicotine patch in the
, 2004
Cognitive correlates of white matter growth and stress hormones in female squirrel monkey adults
, 2004
Neuropsychological correlates of psychotic features in major depressive disorders
, 2004
Pharmacologic treatments of major depression: Are two mechanisms really better than one?
, 2004
The relationship of chronic pain and depression
, 2004
Employing pharmacologic treatment of bipolar disorder to greatest effect
, 2004
Non-schizophrenic psychoses: common and distinguishing features
, 2004
Pharmacogenetics of antidepressant medication intolerance
, 2003
The apolipoprotein E epsilon 4 allele
, 2003
Functiol brain imaging of olfactory processing in monkeys
, 2003
Early materl availability and prefrontal correlates of reward-related memory
, 2003
Onset of major depression during treatment for nicotine dependence
, 2003
A prospective trial of bupropion SR augmentation of partial
, 2003
Regiol alysis of hippocampal activation during memory encoding and retrieval: fMRI study
, 2003
Using chronic pain to predict depressive morbidity in the general population
, 2003
Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor
, 2003
New approaches to maging psychotic depression
, 2003
Euroendocrine aspects of hyperportisolism in major depression
, 2003
Introduction: treating depression and anxiety to remission.
, 2003
Mesotelencephalic dopamine neurochemical responses to glucocorticoid administration
, 2002
Prevalence of depressive episodes with psychotic features in the general population
, 2002
Experience-dependent asymmetric variation in primate prefrontal morphology
, 2002
Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients
, 2002
Pharmacological principles of antidepressant efficacy
, 2002
Relating semantic and episodic memory systems
, 2002
Clinical use of nefazodone in major depression: A 6-year perspective
, 2002
Rapid detection of the C-1496G polymorphism in the CYP2D6*2 allele
, 2001
Early life stress and inherited variation in monkey hippocampal volumes
, 2001
Cortisol activity and cognitive changes in psychotic major depression
, 2001
Rapid reversal of psychotic depression using mifepristone
, 2001
Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486)
, 2001
Sertraline versus imipramine to prevent relapse in chronic depression
, 2001
Corticosteroids and cognition
, 2001
Stress-level cortisol treatment impairs inhibitory control of behavior in monkeys
, 2000
Nicotine patch and paroxetine for smoking cessation
, 2000
Early environmental regulation of glucocorticoid feedback sensitivity in young adult monkeys
, 2000
Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients
, 2000
Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness
, 2000
Cognitive-behavioral group therapy for social phobia in female adolescents
, 2000
Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression
, 2000
Dilative cardiomyopathy leading to congestive heart failure in a male squirrel monkey
, 2000
Clinical efficacy of reboxetine in major depression
, 2000
New indications for antidepressants
, 2000
Posttal experiences and genetic effects on squirrel monkey social affinities and emotiol distress
, 1999
Glucocorticoid effects on mesotelencephalic dopamine neurotransmission
, 1999
Strain differences in mesotelencephalic dopaminergic neurol regulation between Fischer 344
, 1999
Separation induced changes in squirrel monkey hypothalamic-pituitary
, 1999
Phenomenology and treatment of agitation
, 1999
Antidepressant effectiveness in severe depression and melancholia
, 1999
Salivary cortisol levels in socially phobic adolescent girls
, 1999
Serotonergic synergism
, 1998
McLean Hospital Depression Research Facility
, 1998
Posttal foraging demands alter adrenocortical activity and psychosocial development
, 1998
Noradrenergic versus serotonergic antidepressants: Predictors of treatment response
, 1998
Bipolar disorder: Recent issues in diagnosis and classification
, 1998
Serotonin reuptake inhibitor discontinuation syndrome: A hypothetical definition
, 1997
Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome
, 1997
The dymics of sex: Gender differences in psychiatric disorders
, 1997
Treatment of severe depression with the selective serotonin reuptake inhibitors.
, 1996
SEROTONIN ACTIVITY IN PSYCHOTIC (DELUSIOL) MAJOR DEPRESSION
, 1992
What is Dr. Schatzberg's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Schatzberg's National Provider Identifier (NPI) number is 1518093129.
What common questions do patients ask about Dr. Schatzberg?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Schatzberg
What is Dr. Alan Schatzberg's specialty?
Dr. Schatzberg is a Psychiatrist near Stanford, CA.
What does a Psychiatrist do?
A Psychiatrist specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.